Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	911928	911928	G	C	exonic	PERM1	.	synonymous SNV	PERM1:NM_001291366:exon3:c.C2226G:p.T742T,PERM1:NM_001291367:exon4:c.C1944G:p.T648T	.	.	.	.	0.06703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	174	chr1	911928	chr1:911928	G	C	.	PASS	AN=0;DP=174	GT	0/1
chr1	1159236	1159237	GG	-	exonic	SDF4	.	frameshift deletion	SDF4:NM_016176:exon3:c.438_439del:p.F146Lfs*5,SDF4:NM_016547:exon3:c.438_439del:p.F146Lfs*4	0.001309827	0.858724277	0.139965896	.	0.10366	0.35502	-0.598810865	18.13517339	109.15684	2.26829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	331	chr1	1159235	chr1:1159235	CGG	C	77	PASS	AN=2;DP=331	GT	0/1
chr1	16945409	16945409	T	A	ncRNA_exonic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	chr1	16945409	chr1:16945409	T	A	.	PASS	AN=0;DP=191	GT	0/1
chr1	16957374	16957374	C	T	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	439	chr1	16957374	chr1:16957374	C	T	.	PASS	AN=0;DP=439	GT	0/1
chr1	19476308	19476308	A	-	intronic	UBR4	.	.	.	1	2.43E-23	4.94E-62	.	0.25731	0.12662	-7.504914615	0.011795235	2894.47418	10.19251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	37	chr1	19476307	chr1:19476307	GA	G,GAA	61	PASS	AN=2;DP=37	GT	0/1
chr1	19476308	19476308	-	A	intronic	UBR4	.	.	.	1	2.43E-23	4.94E-62	.	0.25731	0.12662	-7.504914615	0.011795235	2894.47418	10.19251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	37	chr1	19476307	chr1:19476307	GA	G,GAA	61	PASS	AN=2;DP=37	GT	0/1
chr1	21799967	21799967	A	T	exonic	NBPF3	.	nonsynonymous SNV	NBPF3:NM_001256417:exon6:c.A619T:p.N207Y,NBPF3:NM_001256416:exon7:c.A829T:p.N277Y,NBPF3:NM_032264:exon7:c.A829T:p.N277Y,NBPF3:NM_001330381:exon11:c.A661T:p.N221Y	1.98E-11	0.378787942	0.621212058	.	0.06699	.	3.60019308	99.52819061	1664.61558	7.53254	0.093	0.682	T	0.999	0.764	D	0.986	0.754	D	.	.	.	1	0.090	N	2.255	0.644	M	3.43	0.055	T	-5.21	0.861	D	0.052	0.494	-1.044	0.162	T	0.034	0.148	T	0.001	0.005	T	1.153	0.205	11.50	0.538	0.049	0.001	0.006	N	c	-0.688	-1.038	0.006	0.111	0.615	0.372	0	-1.8	0.074	-1.030	0.037	-0.882	0.027	0.000	0.063	0.000	0.016	2.840	0.051	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	.	76	chr1	21799967	chr1:21799967	A	T	.	PASS	AN=0;DP=76	GT	0/1
chr1	23954441	23954441	C	T	UTR5	MDS2	NM_001348075:c.-1604C>T	.	.	0.042965573	0.662011892	0.295022535	.	0.06917	.	.	.	3048.37206	10.49529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	193	chr1	23954441	chr1:23954441	C	T	58	PASS	AN=2;DP=193	GT	0/1
chr1	47325354	47325354	G	A	ncRNA_exonic	CYP4Z2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	71	chr1	47325354	chr1:47325354	G	A	69	PASS	AN=2;DP=71	GT	0/1
chr1	51767912	51767912	-	C	intronic	TTC39A	.	.	.	0.098310255	0.901370177	0.000319568	.	0.30275	.	-0.358119787	29.16371786	40.28663	1.18371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	258	chr1	51767912	chr1:51767912	G	GC	122	PASS	AN=2;DP=258	GT	0/1
chr1	112032260	112032260	G	A	intronic	TMIGD3	.	.	.	.	.	.	.	0.10089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	37	chr1	112032260	chr1:112032260	G	A	78	PASS	AN=2;DP=37	GT	0/1
chr1	144879538	144879538	C	T	exonic	PDE4DIP	.	synonymous SNV	PDE4DIP:NM_001350520:exon23:c.G4398A:p.K1466K,PDE4DIP:NM_001198834:exon27:c.G3912A:p.K1304K,PDE4DIP:NM_014644:exon27:c.G3912A:p.K1304K,PDE4DIP:NM_001198832:exon30:c.G3780A:p.K1260K,PDE4DIP:NM_001350521:exon30:c.G4323A:p.K1441K,PDE4DIP:NM_001350522:exon30:c.G4110A:p.K1370K,PDE4DIP:NM_001350523:exon30:c.G3777A:p.K1259K	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	n	0.585	-0.044	1.000	0.439	0.563	0.310	0	2.47	0.290	0.971	0.288	0.900	0.413	0.944	0.326	0.023	0.138	2.944	0.054	.	.	.	0.5	95	314	chr1	144879538	chr1:144879538	C	T	95	PASS	AN=2;DP=314	GT	0/1
chr1	144879542	144879542	A	G	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon23:c.T4394C:p.L1465P,PDE4DIP:NM_001198834:exon27:c.T3908C:p.L1303P,PDE4DIP:NM_014644:exon27:c.T3908C:p.L1303P,PDE4DIP:NM_001198832:exon30:c.T3776C:p.L1259P,PDE4DIP:NM_001350521:exon30:c.T4319C:p.L1440P,PDE4DIP:NM_001350522:exon30:c.T4106C:p.L1369P,PDE4DIP:NM_001350523:exon30:c.T3773C:p.L1258P	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.009	0.244	T	.	.	.	.	.	.	.	.	c	-0.691	-0.660	1.000	0.431	0.563	0.310	0	2.15	0.265	1.568	0.358	0.911	0.421	0.953	0.330	0.054	0.167	8.185	0.303	.	.	.	0.5	104	146	chr1	144879542	chr1:144879542	A	G	104	PASS	AN=2;DP=146	GT	0/1
chr1	145021228	145021228	G	C	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	chr1	145021228	chr1:145021228	G	C	.	PASS	AN=0;DP=76	GT	0/1
chr1	145460233	145460233	G	A	UTR5	POLR3GL	NM_032305:c.-11C>T;NM_001330685:c.-11C>T	.	.	0.002440213	0.928303267	0.069256521	.	0.15289	0.11495	-0.095386216	46.48502005	23.8527	0.78684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	176	chr1	145460233	chr1:145460233	G	A	.	PASS	AN=0;DP=176	GT	0/1
chr1	145532995	145532995	T	-	intronic	ITGA10;NBPF10;NBPF19;NBPF20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	40	chr1	145532994	chr1:145532994	GT	G	103	PASS	AN=2;DP=40	GT	0/1
chr1	146494686	146494686	T	C	ncRNA_intronic	LOC728989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	75	chr1	146494686	chr1:146494686	T	C	122	PASS	AN=2;DP=75	GT	0/1
chr1	148252019	148252019	G	C	exonic	NBPF14;NBPF9	.	nonsynonymous SNV	NBPF9:NM_001277444:exon25:c.C3192G:p.D1064E,NBPF14:NM_015383:exon66:c.C8316G:p.D2772E	.	.	.	.	.	.	.	.	.	.	.	.	.	0.795	0.520	P	0.739	0.573	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.164	0.198	-1.067	0.100	T	0.022	0.094	T	0.001	0.014	T	2.112	0.315	16.93	0.973	0.330	0.006	0.026	N	c	-0.547	-0.839	0.023	0.135	0.706	0.609	0	0.109	0.138	0.337	0.194	0.494	0.279	0.001	0.137	0.001	0.043	.	.	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	105	410	chr1	148252019	chr1:148252019	G	C	105	PASS	AN=2;DP=410	GT	0/1
chr1	149262825	149262825	C	T	intergenic	NBPF25P;FAM231D	dist=153100;dist=25410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	132	chr1	149262825	chr1:149262825	C	T	.	PASS	AN=0;DP=132	GT	0/1
chr1	154963016	154963016	G	C	intronic	FLAD1	.	.	.	0.091793511	0.906439743	0.001766745	.	0.11392	0.23178	-1.043396569	7.71408351	87.62766	1.99904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	157	chr1	154963016	chr1:154963016	G	C	99	PASS	AN=2;DP=157	GT	0/1
chr1	155720557	155720557	T	-	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	57	chr1	155720556	chr1:155720556	CT	C	76	PASS	AN=2;DP=57	GT	0/1
chr1	161829973	161829973	-	T	intronic	ATF6	.	.	.	3.11E-05	0.996993053	0.00297588	.	0.24087	0.27985	0.42259095	77.22929936	3604.57589	11.62279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.66	70	chr1	161829973	chr1:161829973	C	CT,CTT	16.66	PASS	AN=0;DP=70	GT	0/1/.
chr1	161829973	161829973	-	TT	intronic	ATF6	.	.	.	3.11E-05	0.996993053	0.00297588	.	0.24087	0.27985	0.42259095	77.22929936	3604.57589	11.62279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.66	70	chr1	161829973	chr1:161829973	C	CT,CTT	16.66	PASS	AN=0;DP=70	GT	0/1/.
chr1	228494689	228494689	C	T	exonic	OBSCN	.	nonsynonymous SNV	OBSCN:NM_001098623:exon45:c.C12014T:p.A4005V,OBSCN:NM_052843:exon45:c.C12014T:p.A4005V,OBSCN:NM_001271223:exon56:c.C14885T:p.A4962V	5.36E-91	1.17E-06	0.999998832	DISEASE: Note=A chromosomal aberration involving OBSCN has been found in Wilms tumor. Translocation t(1;7)(q42;p15) with PTHB1. {ECO:0000269|PubMed:12618763}.; 	0.1804	0.12775	.	.	33482.92348	35.92354	0.058	0.377	T	0.996	0.670	D	0.792	0.560	P	0.676	0.103	N	1	0.090	N	1.16	0.298	L	3.54	0.048	T	-1.36	0.338	N	0.108	0.132	-0.971	0.371	T	0.034	0.148	T	0.013	0.327	T	1.115	0.201	11.30	0.792	0.122	0.173	0.196	N	c	-0.580	-0.718	0.001	0.077	0.635	0.413	0	0.51	0.161	0.228	0.175	-0.760	0.034	0.000	0.063	0.000	0.016	16.803	0.854	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	71	117	chr1	228494689	chr1:228494689	C	T	71	PASS	AN=2;DP=117	GT	0/1
chr1	236703818	236703818	T	-	intronic	LGALS8	.	.	.	0.000188797	0.896973744	0.102837458	.	0.48105	0.17047	1.063778722	91.58410002	6987.34024	17.79441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	124	chr1	236703817	chr1:236703817	GT	G	62	PASS	AN=2;DP=124	GT	0/1
chr2	10139226	10139226	C	-	intronic	GRHL1	.	.	.	0.983150779	0.016849134	8.72E-08	.	0.18056	0.20109	-0.113792788	45.25831564	1942.58495	8.11174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	152	chr2	10139225	chr2:10139225	AC	A	100	PASS	AN=2;DP=152	GT	0/1
chr2	25830231	25830231	C	T	intronic	DTNB	.	.	.	0.000530412	0.999218122	0.000251466	.	0.59206	0.49987	-0.799052816	12.45576787	225.44054	3.24713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	75	chr2	25830231	chr2:25830231	C	T	97	PASS	AN=2;DP=75	GT	0/1
chr2	32515614	32515614	G	T	exonic	YIPF4	.	stopgain	YIPF4:NM_032312:exon2:c.G142T:p.E48X	0.019788591	0.902081655	0.078129753	.	0.25391	0.10849	0.369407109	74.95281906	43.18158	1.24746	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.498	0.975	37	0.996	0.729	0.981	0.792	D	c	0.897	0.760	1.000	0.747	0.706	0.609	0	4.48	0.538	9.020	0.931	0.953	0.551	1.000	0.715	1.000	0.888	15.872	0.788	.	.	.	0.5	.	83	chr2	32515614	chr2:32515614	G	T	.	PASS	AN=0;DP=83	GT	0/1
chr2	61697840	61697840	-	C	UTR5	USP34	NM_014709:c.-14_-13insG	.	.	1	4.84E-19	7.26E-51	.	0.83824	0.09517	-3.59020415	0.300778485	689.89772	5.23798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	178	chr2	61697840	chr2:61697840	G	GC	63	PASS	AN=2;DP=178	GT	0/1
chr2	87355912	87355912	C	T	intergenic	LOC285074;MIR4771-2	dist=52376;dist=65997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	87	chr2	87355912	chr2:87355912	C	T	105	PASS	AN=2;DP=87	GT	0/1
chr2	96126087	96126087	-	A	intergenic	FAHD2A;TRIM43B	dist=47208;dist=16628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	267	chr2	96126087	chr2:96126087	C	CA	40	PASS	AN=2;DP=267	GT	0/1
chr2	101881539	101881539	-	T	intronic	CNOT11	.	.	.	0.993507645	0.006491339	1.02E-06	.	0.50975	0.09076	-0.361761279	28.6329323	24.35814	0.80124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	221	chr2	101881539	chr2:101881539	C	CT	76	PASS	AN=2;DP=221	GT	0/1
chr2	128412336	128412336	C	-	intronic	LIMS2	.	.	.	1.14E-05	0.585518975	0.414469626	.	0.40061	0.11748	-0.800872469	12.33191791	54.15487	1.46813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	176	chr2	128412335	chr2:128412335	GC	G	59	PASS	AN=2;DP=176	GT	0/1
chr2	175992041	175992041	T	C	intronic	ATF2	.	.	.	0.892244393	0.107746406	9.20E-06	.	0.88198	0.28104	-0.714505427	14.4019816	21.91257	0.73683	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	286	chr2	175992041	chr2:175992041	T	C	74	PASS	AN=2;DP=286	GT	0/1
chr2	178682626	178682626	C	G	exonic	PDE11A	.	nonsynonymous SNV	PDE11A:NM_001077196:exon5:c.G271C:p.D91H,PDE11A:NM_001077358:exon7:c.G529C:p.D177H,PDE11A:NM_016953:exon8:c.G1603C:p.D535H,PDE11A:NM_001077197:exon9:c.G853C:p.D285H	4.17E-31	4.13E-06	0.999995868	DISEASE: Primary pigmented nodular adrenocortical disease 2 (PPNAD2) [MIM:610475]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:16767104}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.14082	0.764222299	86.86010852	1086.94608	6.31598	0.006	0.614	D	1.0	0.899	D	0.991	0.818	D	0.000	0.843	D	1	0.810	D	2.13	0.595	M	-0.27	0.674	T	-4.18	0.755	D	0.857	0.872	-0.678	0.615	T	0.313	0.683	T	0.017	0.394	T	6.515	0.898	31	0.995	0.650	0.986	0.845	D	c	0.353	0.458	1.000	0.747	0.487	0.133	0	5.58	0.843	7.834	0.848	0.920	0.431	1.000	0.715	0.996	0.625	18.355	0.903	GAF domain|GAF domain-like	.	.	0.5	82	21	chr2	178682626	chr2:178682626	C	G	82	PASS	AN=2;DP=21	GT	0/1
chr2	242168924	242168924	G	A	UTR3	HDLBP	NM_001243900:c.*92C>T;NM_001320966:c.*92C>T;NM_005336:c.*92C>T;NM_001320965:c.*92C>T;NM_203346:c.*92C>T	.	.	0.999998383	1.62E-06	6.87E-17	.	0.83358	0.17552	-1.368693559	4.482189196	124.99167	2.43155	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	59	chr2	242168924	chr2:242168924	G	A	123	PASS	AN=2;DP=59	GT	0/1
chr3	13613030	13613030	C	G	exonic	FBLN2	.	stopgain	FBLN2:NM_001004019:exon2:c.C1175G:p.S392X,FBLN2:NM_001165035:exon2:c.C1175G:p.S392X,FBLN2:NM_001998:exon2:c.C1175G:p.S392X	0.629825153	0.370172306	2.54E-06	.	0.76637	0.22472	-1.091439713	6.988676575	754.76604	5.44846	.	.	.	.	.	.	.	.	.	0.016	0.014	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.692	0.629	24.6	0.952	0.259	0.194	0.204	N	c	-0.196	-0.583	0.998	0.368	0.696	0.567	0	-1.13	0.092	0.510	0.223	-0.841	0.030	0.000	0.063	0.000	0.016	8.519	0.322	.	.	.	0.5	71	181	chr3	13613030	chr3:13613030	C	G	71	PASS	AN=2;DP=181	GT	0/1
chr3	56787560	56787560	A	C	exonic	ARHGEF3	.	nonsynonymous SNV	ARHGEF3:NM_001128616:exon4:c.T428G:p.L143W,ARHGEF3:NM_019555:exon4:c.T410G:p.L137W,ARHGEF3:NM_001289698:exon5:c.T428G:p.L143W,ARHGEF3:NM_001128615:exon7:c.T506G:p.L169W	0.991271358	0.008728557	8.58E-08	.	0.32682	0.12378	-0.290161348	33.33923095	2959.45549	10.30538	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.24	0.636	M	-0.01	0.628	T	-4.92	0.837	D	0.898	0.890	0.108	0.843	D	0.492	0.807	T	0.169	0.847	D	5.910	0.811	27.5	0.960	0.278	0.983	0.809	D	c	0.919	0.880	1.0	0.983	0.707	0.730	0	5.63	0.861	8.945	0.925	1.119	0.881	1.000	0.715	1.000	0.888	15.810	0.782	Dbl homology (DH) domain	.	.	0.5	76	37	chr3	56787560	chr3:56787560	A	C	76	PASS	AN=2;DP=37	GT	0/1
chr3	60522571	60522571	-	A	intronic	FHIT	.	.	.	0.001391839	0.662104571	0.33650359	DISEASE: Note=A chromosomal aberration involving FHIT has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT in its 5-prime non-coding region, it is unlikely that FHIT is causally related to renal or other malignancies. {ECO:0000269|PubMed:15007172}.; DISEASE: Note=Associated with digestive tract cancers. Numerous tumor types are found to have aberrant forms of FHIT protein due to deletions in a coding region of chromosome 3p14.2 including the fragile site locus FRA3B. {ECO:0000269|PubMed:15007172}.; 	0.25475	.	-0.560178693	19.30879925	49.36677	1.3751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	28	chr3	60522571	chr3:60522571	C	CA	70	PASS	AN=2;DP=28	GT	0/1
chr3	129811914	129811914	A	T	ncRNA_intronic	LINC02014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	250	chr3	129811914	chr3:129811914	A	T	66	PASS	AN=2;DP=250	GT	0/1
chr3	179333753	179333753	-	T	intronic	NDUFB5	.	.	.	0.003441089	0.835086357	0.161472554	.	0.10317	0.14954	0.147123112	64.11299835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	37	chr3	179333753	chr3:179333753	C	CT	41	PASS	AN=2;DP=37	GT	0/1
chr3	186006618	186006618	G	C	exonic	DGKG	.	nonsynonymous SNV	DGKG:NM_001080744:exon6:c.C425G:p.T142S,DGKG:NM_001080745:exon6:c.C425G:p.T142S,DGKG:NM_001346:exon6:c.C425G:p.T142S	5.44E-06	0.99850148	0.001493082	.	0.45176	0.18992	-1.524862616	3.42061807	110.98235	2.29646	0.814	0.033	T	0.002	0.090	B	0.006	0.133	B	0.914	0.085	N	1	0.090	P	0.695	0.181	N	1.0	0.414	T	0.04	0.065	N	0.057	0.040	-0.922	0.453	T	0.000	0.000	T	.	.	.	-1.570	0.015	0.002	0.428	0.032	0.063	0.122	N	c	-1.255	-1.199	0.996	0.343	0.487	0.133	0	2.16	0.265	1.920	0.394	-0.752	0.034	0.802	0.295	0.000	0.016	5.379	0.154	Diacylglycerol kinase type I, N-terminal	.	.	0.5	138	71	chr3	186006618	chr3:186006618	G	C	138	PASS	AN=2;DP=71	GT	0/1
chr3	196159011	196159011	G	-	ncRNA_intronic	UBXN7-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	235	chr3	196159010	chr3:196159010	CG	C	76	PASS	AN=2;DP=235	GT	0/1
chr4	343795	343795	-	TGCT	intronic	ZNF141	.	.	.	0.161888983	0.82300848	0.015102537	.	0.39436	0.16446	0.795569043	87.49115357	156.94519	2.73623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	25	chr4	343795	chr4:343795	C	CTGCT	96	PASS	AN=2;DP=25	GT	0/1
chr4	3498664	3498664	A	G	intronic	DOK7	.	.	.	0.004808382	0.881308685	0.113882933	DISEASE: Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS10 is an autosomal recessive, post-synaptic form characterized by a typical 'limb girdle' pattern of muscle weakness with small, simplified neuromuscular junctions but normal acetylcholine receptor and acetylcholinesterase function. {ECO:0000269|PubMed:16917026, ECO:0000269|PubMed:17439981, ECO:0000269|PubMed:20012313, ECO:0000269|PubMed:22661499}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1712	.	.	.	2606.59203	9.55466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr4	3498664	chr4:3498664	A	G	.	PASS	AN=0;DP=112	GT	0/1
chr4	77969239	77969239	-	T	UTR3	CCNI	NM_001348133:c.*132_*133insA;NM_001348132:c.*132_*133insA;NM_001348134:c.*132_*133insA;NM_001348135:c.*132_*133insA;NM_001348136:c.*132_*133insA;NM_001348137:c.*132_*133insA;NM_001348138:c.*132_*133insA;NM_001348139:c.*132_*133insA;NM_001348140:c.*557_*558insA;NM_006835:c.*132_*133insA	.	.	0.789094043	0.209550825	0.001355133	.	0.26347	0.16383	0.104848986	61.49445624	48.69159	1.3608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	43	chr4	77969239	chr4:77969239	A	AT	42	PASS	AN=2;DP=43	GT	0/1
chr4	89443189	89443189	-	A	intronic	PIGY;PYURF	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	19	chr4	89443189	chr4:89443189	G	GA	39	PASS	AN=2;DP=19	GT	0/1
chr4	102076260	102076260	A	C	intronic	PPP3CA	.	.	.	0.998148789	0.001851202	9.61E-09	.	0.91458	0.30319	-0.427900189	25.14744043	6.37885	0.23918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	334	chr4	102076260	chr4:102076260	A	C	97	PASS	AN=2;DP=334	GT	0/1
chr5	5146432	5146432	G	A	exonic	ADAMTS16	.	nonsynonymous SNV	ADAMTS16:NM_139056:exon3:c.G365A:p.G122D	0.001086503	0.998912754	7.44E-07	.	0.15638	0.1321	0.679686641	84.77235197	6129.25449	16.35226	0.834	0.029	T	0.995	0.657	D	0.927	0.644	D	0.000	0.843	D	1	0.810	D	2.105	0.586	M	3.23	0.070	T	-3.44	0.674	D	0.877	0.871	-1.220	0.001	T	0.070	0.284	T	0.010	0.267	T	3.336	0.460	22.9	0.823	0.136	0.857	0.446	D	c	0.266	0.244	1.0	0.983	0.707	0.730	0	5.74	0.900	7.272	0.777	1.048	0.713	1.000	0.715	0.648	0.298	19.069	0.931	Peptidase M12B, propeptide	.	.	0.5	.	72	chr5	5146432	chr5:5146432	G	A	.	PASS	AN=0;DP=72	GT	0/1
chr5	7300363	7300383	GCTTCCGCATCTGCTCTTTCT	-	intergenic	MIR4454;LOC442132	dist=30896;dist=1060	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	360	chr5	7300362	chr5:7300362	CGCTTCCGCATCTGCTCTTTCT	C	67	PASS	AN=2;DP=360	GT	0/1
chr5	141691634	141691634	G	A	UTR3	SPRY4	NM_030964:c.*2140C>T;NM_001293289:c.*2140C>T;NM_001293290:c.*2140C>T;NM_001127496:c.*2140C>T	.	.	0.109919686	0.776973195	0.11310712	DISEASE: Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:23643382}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in SPRY4 also have a heterozygous mutation in another HH-associated gene including DUSP6 and FGFR1 (PubMed:23643382). {ECO:0000269|PubMed:23643382}.; 	0.93024	0.1419	-0.045835247	50.34206181	112.70425	2.30891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	99	chr5	141691634	chr5:141691634	G	A	53	PASS	AN=2;DP=99	GT	0/1
chr5	145719086	145719086	G	A	intronic	POU4F3	.	.	.	0.721115139	0.275871589	0.003013271	.	0.89518	0.15588	-0.53631094	20.53550366	20.59903	0.70015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	90	chr5	145719086	chr5:145719086	G	A	.	PASS	AN=0;DP=90	GT	0/1
chr5	147162132	147162132	-	T	UTR5	JAKMIP2	NM_014790:c.-110764_-110763insA;NM_001270934:c.-110764_-110763insA;NM_001282282:c.-112_-111insA;NM_001270941:c.-110764_-110763insA	.	.	0.999936528	6.35E-05	1.06E-13	.	0.66287	0.12537	-1.199555187	5.761972163	105.04961	2.21693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	79	chr5	147162132	chr5:147162132	G	GT	51	PASS	AN=2;DP=79	GT	0/1
chr6	36322471	36322471	-	A	intronic	ETV7	.	.	.	2.01E-08	0.245599352	0.754400627	.	0.70881	.	1.243805243	93.41825902	433.45398	4.34535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	84	chr6	36322471	chr6:36322471	T	TA	65	PASS	AN=2;DP=84	GT	0/1
chr6	41126404	41126404	G	C	exonic	TREM2	.	synonymous SNV	TREM2:NM_001271821:exon4:c.C597G:p.L199L	2.35E-08	0.041595266	0.958404711	.	0.04385	0.1552	0.483275131	79.25218212	446.17961	4.3976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	102	chr6	41126404	chr6:41126404	G	C	87	PASS	AN=2;DP=102	GT	0/1
chr6	168355107	168355107	-	T	intronic	AFDN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	63	chr6	168355107	chr6:168355107	C	CT	52	PASS	AN=2;DP=63	GT	0/1
chr7	27236557	27236557	-	T	UTR3	HOXA13	NM_000522:c.*1259_*1260insA	.	.	.	.	.	DISEASE: Hand-foot-genital syndrome (HFG) [MIM:140000]: A disorder characterized by limb and genitourinary anomalies. Clinical features include small feet with unusually short great toes and abnormal thumbs. Females with the disorder have duplication of the genital tract. {ECO:0000269|PubMed:10839976, ECO:0000269|PubMed:12073020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Guttmacher syndrome (GUTTS) [MIM:176305]: Dominantly inherited combination of distal limb and genital tract abnormalities. It has several features in common with hand-foot- genital syndrome, including hypoplastic first digits and hypospadias. Typical features not seen in hand-foot-genital syndrome include postaxial polydactyly of the hands and uniphalangeal second toes with absent nails. {ECO:0000269|PubMed:11968094}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.68929	.	.	.	122.9053	2.41409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	100	chr7	27236557	chr7:27236557	G	GT	62	PASS	AN=2;DP=100	GT	0/1
chr7	44553195	44553195	C	A	exonic	NPC1L1	.	nonsynonymous SNV	NPC1L1:NM_001101648:exon19:c.G3850T:p.V1284L,NPC1L1:NM_013389:exon20:c.G3931T:p.V1311L	1.37E-10	0.983840205	0.016159795	.	0.12878	0.1868	1.377872212	94.53880632	380.20775	4.11083	0.116	0.294	T	0.0	0.026	B	0.0	0.013	B	0.000	0.002	N	1	0.090	N	0	0.065	N	-0.01	0.628	T	-0.15	0.093	N	0.033	0.031	-1.012	0.264	T	0.121	0.423	T	0.004	0.088	T	0.564	0.148	7.901	0.895	0.183	0.023	0.066	N	c	-1.137	-1.156	0.000	0.052	0.554	0.246	0	0.684	0.171	0.212	0.172	-0.345	0.071	0.000	0.063	0.000	0.016	7.574	0.269	.	.	.	0.5	.	80	chr7	44553195	chr7:44553195	C	A	.	PASS	AN=0;DP=80	GT	0/1
chr7	55259515	55259515	T	G	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_001346941:exon15:c.T1772G:p.L591R,EGFR:NM_001346897:exon20:c.T2438G:p.L813R,EGFR:NM_001346899:exon20:c.T2438G:p.L813R,EGFR:NM_001346898:exon21:c.T2573G:p.L858R,EGFR:NM_001346900:exon21:c.T2414G:p.L805R,EGFR:NM_005228:exon21:c.T2573G:p.L858R	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	0.0	0.912	D	0.999	0.899	D	0.956	0.916	D	0.000	0.504	D	1.000	0.810	D	3.65	0.943	H	-2.83	0.913	D	-5.23	0.839	D	0.989	0.993	0.987	0.970	D	0.881	0.960	D	0.698	0.975	D	6.930	0.933	33	0.998	0.896	0.981	0.798	D	c	0.927	0.868	1.000	0.747	0.741	0.978	0	5.71	0.890	7.960	0.873	1.061	0.807	1.000	0.715	1.000	0.888	14.811	0.695	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain	.	.	0.5	113	124	chr7	55259515	chr7:55259515	T	G	113	PASS	AN=2;DP=124	GT	0/1
chr7	57245934	57245934	C	A	ncRNA_exonic	GUSBP10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	386	chr7	57245934	chr7:57245934	C	A	64	PASS	AN=2;DP=386	GT	0/1
chr7	101921209	101921209	-	C	intronic	CUX1	.	.	.	0.999988878	1.11E-05	3.08E-16	.	0.78386	0.44868	-1.868734056	2.011087521	217.29988	3.18613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	469	chr7	101921209	chr7:101921209	T	TC	81	PASS	AN=2;DP=469	GT	0/1
chr7	128255933	128255933	G	A	intergenic	METTL2B;LINC01000	dist=112955;dist=25362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	41	chr7	128255933	chr7:128255933	G	A	58	PASS	AN=2;DP=41	GT	0/1
chr7	131113756	131113756	-	T	intronic	MKLN1	.	.	.	0.999577505	0.000422495	5.31E-11	.	0.35761	0.14611	-0.427900189	25.14744043	19.26303	0.66403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	49	chr7	131113756	chr7:131113756	C	CT	67	PASS	AN=2;DP=49	GT	0/1
chr7	151962290	151962290	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon8:c.G1017C:p.K339N	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.246	0.173	T	0.999	0.764	D	0.991	0.782	D	0.001	0.432	U	0.938	0.372	D	1.445	0.365	L	-5.16	0.988	D	-2.17	0.490	N	0.153	0.189	0.881	0.954	D	0.928	0.976	D	.	.	.	2.356	0.344	18.53	0.986	0.425	0.867	0.457	D	c	-0.067	-0.115	0.503	0.209	0.707	0.730	0	3.77	0.423	1.960	0.398	0.802	0.324	1.000	0.715	0.997	0.653	11.249	0.481	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Zinc finger, FYVE/PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	94	120	chr7	151962290	chr7:151962290	C	G	94	PASS	AN=2;DP=120	GT	0/1
chr7	151970710	151970710	C	A	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	212	chr7	151970710	chr7:151970710	C	A	120	PASS	AN=2;DP=212	GT	0/1
chr7	151970797	151970797	A	T	exonic	KMT2C	.	synonymous SNV	KMT2C:NM_170606:exon7:c.T1005A:p.P335P	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	426	chr7	151970797	chr7:151970797	A	T	109	PASS	AN=2;DP=426	GT	0/1
chr7	152841603	152841603	C	A	intergenic	ACTR3B;LINC01287	dist=289139;dist=255401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	chr7	152841603	chr7:152841603	C	A	.	PASS	AN=0;DP=48	GT	0/1
chr8	1616806	1616806	G	A	exonic	DLGAP2	.	nonsynonymous SNV	DLGAP2:NM_001346810:exon9:c.G2122A:p.E708K	0.950397326	0.049601404	1.27E-06	.	0.18261	0.10991	-1.609459583	3.001887238	.	.	0.217	0.191	T	0.604	0.389	P	0.392	0.424	B	0.000	0.477	D	0.849	0.352	D	2.2	0.622	M	2.24	0.179	T	-1.1	0.285	N	0.404	0.463	-1.066	0.103	T	0.047	0.200	T	0.004	0.096	T	1.438	0.236	12.99	0.984	0.402	0.971	0.725	D	c	-0.068	-0.057	1.000	0.747	0.487	0.133	0	4.7	0.586	6.254	0.722	1.048	0.713	1.000	0.715	0.030	0.147	14.818	0.695	.	.	.	0.5	98	158	chr8	1616806	chr8:1616806	G	A	98	PASS	AN=2;DP=158	GT	0/1
chr8	10753653	10753653	-	T	downstream	XKR6	dist=4	.	.	0.956776701	0.043218854	4.45E-06	.	0.31948	0.1039	-0.824740496	11.67728238	40.49271	1.18751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	167	chr8	10753653	chr8:10753653	C	CT	67	PASS	AN=2;DP=167	GT	0/1
chr8	17088039	17088039	-	T	UTR3	CNOT7	NM_013354:c.*189_*190insA;NM_001322091:c.*189_*190insA;NM_001322092:c.*189_*190insA;NM_001322093:c.*189_*190insA;NM_001322095:c.*189_*190insA;NM_001322096:c.*189_*190insA;NM_001322097:c.*189_*190insA;NM_001322090:c.*189_*190insA	.	.	0.986495484	0.013498412	6.10E-06	.	0.82396	0.11262	-0.141298762	42.87567823	5.94172	0.22349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	36	chr8	17088039	chr8:17088039	G	GT	51	PASS	AN=2;DP=36	GT	0/1
chr8	52733079	52733079	A	C	exonic	PCMTD1	.	nonsynonymous SNV	PCMTD1:NM_001286782:exon4:c.T678G:p.S226R,PCMTD1:NM_001286783:exon6:c.T378G:p.S126R,PCMTD1:NM_052937:exon6:c.T906G:p.S302R	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	0.069	0.496	T	0.999	0.764	D	0.994	0.807	D	0.000	0.629	N	1.000	0.588	D	1.955	0.530	M	0.98	0.421	T	-0.9	0.468	N	0.411	0.776	-0.920	0.455	T	0.174	0.518	T	.	.	.	1.490	0.241	13.26	0.998	0.850	0.846	0.434	D	c	0.047	0.054	0.982	0.303	0.707	0.730	0	0.773	0.176	1.452	0.345	0.237	0.263	1.000	0.715	0.999	0.750	6.433	0.209	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	80	71	chr8	52733079	chr8:52733079	A	C	80	PASS	AN=2;DP=71	GT	0/1
chr8	144406691	144406691	G	C	exonic	TOP1MT	.	nonsynonymous SNV	TOP1MT:NM_001258447:exon6:c.C486G:p.I162M,TOP1MT:NM_052963:exon6:c.C780G:p.I260M,TOP1MT:NM_001258446:exon7:c.C486G:p.I162M	1.63E-19	0.001500191	0.998499809	.	0.18543	0.14812	-0.435396074	24.70511913	3501.83574	11.39955	0.052	0.395	T	0.95	0.519	P	0.864	0.597	P	0.125	0.189	U	0.739	0.338	D	2.215	0.627	M	0.91	0.449	T	-1.66	0.416	N	0.263	0.435	-0.797	0.553	T	0.150	0.478	T	0.005	0.141	T	2.172	0.322	17.33	0.991	0.510	0.737	0.358	D	c	-0.035	-0.191	0.993	0.331	0.707	0.730	0	1.66	0.230	0.250	0.179	0.797	0.323	0.998	0.411	0.184	0.214	0.936	0.012	DNA topoisomerase I, DNA binding, eukaryotic-type|DNA topoisomerase I, DNA binding, mixed alpha/beta motif, eukaryotic-type;DNA topoisomerase I, DNA binding, eukaryotic-type|DNA topoisomerase I, DNA binding, mixed alpha/beta motif, eukaryotic-type|DNA topoisomerase I, eukaryotic-type	.	.	0.5	140	351	chr8	144406691	chr8:144406691	G	C	140	PASS	AN=2;DP=351	GT	0/1
chr9	8449660	8449660	T	C	intronic	PTPRD	.	.	.	0.999999982	1.80E-08	4.88E-23	.	0.89661	0.17382	-3.078871465	0.483604624	1565.5627	7.32256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	59	chr9	8449660	chr9:8449660	T	C	131	PASS	AN=2;DP=59	GT	0/1
chr9	21202073	21202073	C	G	exonic	IFNA7	.	nonsynonymous SNV	IFNA7:NM_021057:exon1:c.G92C:p.S31T	9.02E-05	0.189291662	0.810618153	.	0.03655	.	1.038098315	91.20665251	30.6513	0.97504	0.086	0.326	T	0.032	0.189	B	0.047	0.234	B	0.838	0.090	N	1	0.090	N	2.33	0.670	M	3.94	0.034	T	-1.4	0.346	N	0.107	0.114	-0.915	0.463	T	0.013	0.052	T	0.002	0.036	T	-1.314	0.022	0.004	0.855	0.154	0.038	0.090	N	c	-1.105	-1.220	0.000	0.041	0.447	0.083	0	-0.052	0.131	-0.605	0.057	-0.088	0.118	0.000	0.063	0.002	0.062	3.153	0.061	Four-helical cytokine, core|Four-helical cytokine-like, core	.	.	0.5	61	106	chr9	21202073	chr9:21202073	C	G	61	PASS	AN=2;DP=106	GT	0/1
chr9	33387111	33387111	G	A	intronic	AQP7	.	.	.	1.86E-09	0.034706833	0.965293165	.	0.0624	0.1324	0.108486928	61.90728946	500.92929	4.59263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	362	chr9	33387111	chr9:33387111	G	A	.	PASS	AN=0;DP=362	GT	0/1
chr9	34665603	34665603	C	A	intronic	LOC730098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	725	chr9	34665603	chr9:34665603	C	A	79	PASS	AN=2;DP=725	GT	0/1
chr9	66457523	66457526	TTTG	-	ncRNA_intronic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	379	chr9	66457522	chr9:66457522	CTTTG	C	123	PASS	AN=2;DP=379	GT	0/1
chr9	117053128	117053128	C	A	exonic	COL27A1	.	synonymous SNV	COL27A1:NM_032888:exon48:c.C4407A:p.G1469G	0.999999361	6.39E-07	9.95E-23	DISEASE: Steel syndrome (STLS) [MIM:615155]: A syndrome characterized by dislocated hips and radial heads, fusion of carpal bones, short stature, scoliosis, and cervical spine anomalies. Facial features include prominent forehead, long oval- shaped face, hypertelorism and broad nasal bridge. {ECO:0000269|PubMed:24986830}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.70075	.	0.170613481	65.33970276	8956.48219	20.50775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chr9	117053128	chr9:117053128	C	A	.	PASS	AN=0;DP=47	GT	0/1
chr9	136083528	136083528	T	A	exonic	OBP2B	.	nonsynonymous SNV	OBP2B:NM_001288987:exon3:c.A269T:p.Y90F,OBP2B:NM_014581:exon3:c.A269T:p.Y90F	0.182972936	0.764684023	0.052343041	.	0.07451	.	0.593509966	82.51356452	9.30105	0.3415	0.297	0.146	T	0.393	0.329	B	0.257	0.376	B	0.027	0.259	N	1	0.192	N	1.055	0.270	L	3.25	0.068	T	-2.4	0.527	N	0.059	0.303	-0.959	0.394	T	0.012	0.048	T	.	.	.	-0.834	0.039	0.036	0.146	0.003	0.002	0.012	N	c	-1.564	-1.642	0.002	0.092	0.487	0.133	0	0.679	0.171	-0.405	0.072	-0.573	0.046	0.001	0.137	0.016	0.126	5.651	0.168	Calycin|Calycin-like|Lipocalin/cytosolic fatty-acid binding domain	.	.	0.5	.	286	chr9	136083528	chr9:136083528	T	A	.	PASS	AN=0;DP=286	GT	0/1
chr9	137600270	137600270	T	-	intronic	COL5A1	.	.	.	1	2.48E-13	8.59E-33	DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10602121, ECO:0000269|PubMed:11992482, ECO:0000269|PubMed:15580559, ECO:0000269|PubMed:18972565, ECO:0000269|PubMed:9042913}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69297	.	-3.009169053	0.524887945	863.84203	5.72906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	215	chr9	137600269	chr9:137600269	GT	G	98	PASS	AN=2;DP=215	GT	0/1
chr10	3208567	3208567	-	GCACGCTAGGGAAGAGAGAGGAATG	exonic	PITRM1	.	stopgain	PITRM1:NM_001242309:exon3:c.175_176insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q59Pfs*6,PITRM1:NM_001242307:exon4:c.271_272insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q91Pfs*6,PITRM1:NM_001347725:exon4:c.271_272insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q91Pfs*6,PITRM1:NM_001347729:exon4:c.247_248insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q83Pfs*6,PITRM1:NM_001347730:exon4:c.247_248insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q83Pfs*6,PITRM1:NM_014889:exon4:c.271_272insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q91Pfs*6	7.16E-16	0.192931146	0.807068854	.	0.09989	0.1727	3.215903205	99.35715971	3783.48611	12.04965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	28	chr10	3208567	chr10:3208567	T	TGCACGCTAGGGAAGAGAGAGGAATG	93	PASS	AN=2;DP=28	GT	0/1
chr10	75835805	75835805	C	T	intronic	VCL	.	.	.	0.994870402	0.005129598	3.92E-11	DISEASE: Cardiomyopathy, dilated 1W (CMD1W) [MIM:611407]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11815424, ECO:0000269|PubMed:16236538}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 15 (CMH15) [MIM:613255]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:16712796}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.84455	.	-1.793112871	2.229299363	332.65362	3.87638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	91	chr10	75835805	chr10:75835805	C	T	98	PASS	AN=2;DP=91	GT	0/1
chr10	87966306	87966306	G	A	exonic	GRID1	.	nonsynonymous SNV	GRID1:NM_017551:exon3:c.C335T:p.P112L	0.950796126	0.049203622	2.52E-07	.	0.40271	0.11711	-2.100076584	1.545175749	701.32829	5.26849	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	1.04	0.263	L	-2.92	0.918	D	-8.09	0.967	D	0.968	0.968	0.862	0.952	D	0.864	0.955	D	0.548	0.958	D	6.467	0.892	29.9	0.999	0.984	0.994	0.960	D	c	0.959	0.963	1.000	0.747	0.554	0.283	0	6.06	0.983	9.988	0.992	1.048	0.713	1.000	0.715	0.999	0.750	19.609	0.956	Periplasmic binding protein-like I|Receptor, ligand binding region	.	.	0.5	92	59	chr10	87966306	chr10:87966306	G	A	92	PASS	AN=2;DP=59	GT	0/1
chr10	88760253	88760253	C	T	intronic	AGAP11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	183	chr10	88760253	chr10:88760253	C	T	83	PASS	AN=2;DP=183	GT	0/1
chr10	101542578	101542578	C	T	UTR5	ABCC2	NM_000392:c.-24C>T	.	.	3.36E-29	0.002811963	0.997188037	.	0.10813	0.23913	0.955252644	90.09200283	1270.67962	6.71605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	26	chr10	101542578	chr10:101542578	C	T	83	PASS	AN=2;DP=26	GT	0/1
chr10	102265084	102265084	A	C	intronic	SEC31B	.	.	.	1.30E-24	0.001046577	0.998953423	.	0.06552	0.07762	2.081666378	97.82377919	8025.98175	19.31489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	49	chr10	102265084	chr10:102265084	A	C	96	PASS	AN=2;DP=49	GT	0/1
chr10	123241642	123241642	C	T	UTR3	FGFR2	NM_001144913:c.*44G>A;NM_001144919:c.*44G>A	.	.	0.999752493	0.000247507	1.44E-11	DISEASE: Crouzon syndrome (CS) [MIM:123500]: An autosomal dominant syndrome characterized by craniosynostosis, hypertelorism, exophthalmos and external strabismus, parrot-beaked nose, short upper lip, hypoplastic maxilla, and a relative mandibular prognathism. {ECO:0000269|PubMed:10574673, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7655462, ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:8946174, ECO:0000269|PubMed:8956050, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9152842, ECO:0000269|PubMed:9521581, ECO:0000269|PubMed:9677057, ECO:0000269|Ref.10}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jackson-Weiss syndrome (JWS) [MIM:123150]: An autosomal dominant craniosynostosis syndrome characterized by craniofacial abnormalities and abnormality of the feet: broad great toes with medial deviation and tarsal-metatarsal coalescence. {ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9385368, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Apert syndrome (APRS) [MIM:101200]: A syndrome characterized by facio-cranio-synostosis, osseous and membranous syndactyly of the four extremities, and midface hypoplasia. The craniosynostosis is bicoronal and results in acrocephaly of brachysphenocephalic type. Syndactyly of the fingers and toes may be total (mitten hands and sock feet) or partial affecting the second, third, and fourth digits. Intellectual deficit is frequent and often severe, usually being associated with cerebral malformations. {ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7668257, ECO:0000269|PubMed:7719344, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9452027, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pfeiffer syndrome (PS) [MIM:101600]: A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3). {ECO:0000269|PubMed:10394936, ECO:0000269|PubMed:10945669, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7719333, ECO:0000269|PubMed:7719345, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9150725, ECO:0000269|PubMed:9693549, ECO:0000269|PubMed:9719378}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Beare-Stevenson cutis gyrata syndrome (BSTVS) [MIM:123790]: An autosomal dominant disease characterized by craniofacial anomalies, particularly craniosynostosis, and ear defects, cutis gyrata, acanthosis nigricans, anogenital anomalies, skin tags, and prominent umbilical stump. The skin furrows have a corrugated appearance and are widespread. Cutis gyrata variably affects the scalp, forehead, face, preauricular area, neck, trunk, hands, and feet. {ECO:0000269|PubMed:12000365, ECO:0000269|PubMed:8696350}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial scaphocephaly syndrome (FSPC) [MIM:609579]: An autosomal dominant craniosynostosis syndrome characterized by scaphocephaly, macrocephaly, hypertelorism, maxillary retrusion, and mild intellectual disability. Scaphocephaly is the most common of the craniosynostosis conditions and is characterized by a long, narrow head. It is due to premature fusion of the sagittal suture or from external deformation. {ECO:0000269|PubMed:16061565}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730]: An autosomal dominant ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Lacrimo-auriculo-dento-digital syndrome is characterized by aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. In addition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitalia have been reported. Craniosynostosis and severe syndactyly are not observed. {ECO:0000269|PubMed:16501574}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410]: A rare syndrome characterized by craniosynostosis, radiohumeral synostosis present from the perinatal period, midface hypoplasia, choanal stenosis or atresia, femoral bowing and multiple joint contractures. Arachnodactyly and/or camptodactyly have also been reported. {ECO:0000269|PubMed:10633130}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bent bone dysplasia syndrome (BBDS) [MIM:614592]: A perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Dysmorphic facial features included low-set ears, hypertelorism, midface hypoplasia, prematurely erupted fetal teeth, and micrognathia. {ECO:0000269|PubMed:22387015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96396	0.7628	-1.50462206	3.568058504	593.43974	4.93642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	91	chr10	123241642	chr10:123241642	C	T	41	PASS	AN=2;DP=91	GT	0/1
chr10	131909019	131909019	G	A	ncRNA_exonic	LINC00959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	chr10	131909019	chr10:131909019	G	A	.	PASS	AN=0;DP=99	GT	0/1
chr11	17664953	17664953	C	T	intronic	OTOG	.	.	.	.	.	.	DISEASE: Deafness, autosomal recessive, 18B (DFNB18B) [MIM:614945]: A form of non-syndromic deafness characterized by a moderate hearing impairment, which can be associated with vestibular dysfunction, and a flat to shallow "U" or slightly downsloping shaped audiograms. {ECO:0000269|PubMed:23122587}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08265	.	.	.	14123.45118	25.75321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	chr11	17664953	chr11:17664953	C	T	.	PASS	AN=0;DP=71	GT	0/1
chr11	62416325	62416325	G	C	exonic	INTS5	.	nonsynonymous SNV	INTS5:NM_030628:exon2:c.C1227G:p.F409L	0.999284368	0.000715627	4.68E-09	.	0.31626	0.12936	-0.971800989	8.946685539	92.50703	2.06784	0.369	0.116	T	0.106	0.245	B	0.25	0.373	B	0.000	0.843	D	0.907	0.276	N	1.1	0.281	L	.	.	.	-1.23	0.312	N	0.505	0.549	-1.009	0.273	T	0.081	0.320	T	0.007	0.184	T	2.926	0.412	22.0	0.803	0.127	0.968	0.708	D	c	-0.371	-0.239	0.996	0.341	0.737	0.974	0	2.92	0.329	1.921	0.394	0.135	0.219	1.000	0.715	0.997	0.653	6.528	0.214	Integrator complex subunit 5, C-terminal	.	.	0.5	68	146	chr11	62416325	chr11:62416325	G	C	68	PASS	AN=2;DP=146	GT	0/1
chr11	70317174	70317174	-	T	UTR3	SHANK2	NM_133266:c.*1799_*1800insA;NM_012309:c.*1799_*1800insA	.	.	0.99992017	7.98E-05	2.24E-11	DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.35021	.	.	.	1233.68596	6.63651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	66	chr11	70317174	chr11:70317174	G	GT	53	PASS	AN=2;DP=66	GT	0/1
chr11	70348982	70348982	G	A	exonic	SHANK2	.	nonsynonymous SNV	SHANK2:NM_133266:exon3:c.C352T:p.R118W	0.99992017	7.98E-05	2.24E-11	DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.35021	.	.	.	1233.68596	6.63651	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	2.62	0.769	M	1.48	0.317	T	-7.03	0.956	D	0.829	0.916	-0.366	0.731	T	0.256	0.626	T	0.126	0.808	D	7.972	0.956	35	0.999	0.991	0.984	0.823	D	c	0.864	0.781	1.000	0.747	0.696	0.567	0	4.46	0.534	9.253	0.947	1.045	0.669	1.000	0.715	1.000	0.888	17.503	0.876	PDZ domain	.	.	0.5	88	430	chr11	70348982	chr11:70348982	G	A	88	PASS	AN=2;DP=430	GT	0/1
chr11	71290790	71290790	-	CAGCAGCTGGACTGGGAGCAGCAGGACCTG	intergenic	KRTAP5-10;KRTAP5-11	dist=13124;dist=2111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	115	chr11	71290790	chr11:71290790	A	ACAGCAGCTGGACTGGGAGCAGCAGGACCTG	43	PASS	AN=2;DP=115	GT	0/1
chr11	72549649	72549649	-	A	UTR3	FCHSD2	NM_014824:c.*186_*187insT	.	.	0.994752587	0.005247408	5.00E-09	.	0.39961	0.11323	-0.88906181	10.36801132	103.87407	2.20142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	151	chr11	72549649	chr11:72549649	C	CA	58	PASS	AN=2;DP=151	GT	0/1
chr11	76807293	76807293	C	G	intronic	CAPN5	.	.	.	3.54E-07	0.935601786	0.06439786	.	0.23811	0.11589	-0.903841325	10.14390186	410.70074	4.24742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	523	chr11	76807293	chr11:76807293	C	G	88	PASS	AN=2;DP=523	GT	0/1
chr11	101765595	101765595	-	A	intronic	ANGPTL5	.	.	.	1.75E-11	0.015997561	0.984002439	.	0.14304	0.10715	0.374860183	75.43052607	415.57896	4.26813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	425	chr11	101765595	chr11:101765595	T	TA	75	PASS	AN=2;DP=425	GT	0/1
chr11	117900392	117900392	G	T	ncRNA_intronic	TMPRSS4-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.837	0.529	T	0.132	0.443	T	.	.	.	0.345	0.127	6.122	0.820	0.135	0.012	0.042	N	c	-0.635	-0.855	0.805	0.242	0.056	0.006	0	-0.625	0.109	-0.071	0.114	0.635	0.291	0.132	0.232	0.392	0.253	5.668	0.169	.	.	.	0.5	.	115	chr11	117900392	chr11:117900392	G	T	.	PASS	AN=0;DP=115	GT	0/1
chr12	7170167	7170167	-	T	intronic	C1S	.	.	.	0.863410048	0.136586473	3.48E-06	DISEASE: Complement component C1s deficiency (C1SD) [MIM:613783]: A rare defect resulting in C1 deficiency and impaired activation of the complement classical pathway. C1 deficiency generally leads to severe immune complex disease with features of systemic lupus erythematosus and glomerulonephritis. {ECO:0000269|PubMed:11390518}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18965	0.44275	-0.044015879	50.44821892	1211.71237	6.58867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	34	chr12	7170167	chr12:7170167	A	AT	52	PASS	AN=2;DP=34	GT	0/1
chr12	70729217	70729217	G	A	splicing	CNOT2	NM_014515:exon8:c.650-1G>A;NM_001199302:exon9:c.650-1G>A;NM_001199303:exon8:c.650-1G>A	.	.	0.999868597	0.000131403	7.53E-11	.	0.28744	0.14229	-0.117432389	44.89266336	17.74579	0.62027	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.134	0.692	25.4	0.993	0.599	0.991	0.916	D	c	1.203	1.041	1.000	0.747	0.322	0.047	0	5.37	0.769	9.882	0.985	0.953	0.551	1.000	0.715	0.982	0.498	19.484	0.950	.	.	.	0.5	75	132	chr12	70729217	chr12:70729217	G	A	75	PASS	AN=2;DP=132	GT	0/1
chr12	77216331	77216333	TTT	-	intronic	ZDHHC17	.	.	.	0.998394624	0.001605369	6.79E-09	.	0.57991	0.2033	-0.159704656	41.90846898	464.21173	4.46413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.41	53	chr12	77216330	chr12:77216330	ATTT	A,AT	23.41	PASS	AN=0;DP=53	GT	0/1
chr12	77216332	77216333	TT	-	intronic	ZDHHC17	.	.	.	0.998394624	0.001605369	6.79E-09	.	0.57991	0.2033	-0.159704656	41.90846898	464.21173	4.46413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.41	53	chr12	77216330	chr12:77216330	ATTT	A,AT	23.41	PASS	AN=0;DP=53	GT	0/1
chr12	108913292	108913292	-	A	UTR3	FICD	NM_007076:c.*40_*41insA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	141	chr12	108913292	chr12:108913292	G	GA	51	PASS	AN=2;DP=141	GT	0/1
chr12	125397648	125397648	G	A	exonic	UBC	.	nonsynonymous SNV	UBC:NM_021009:exon2:c.C670T:p.R224C	0.704156667	0.292254881	0.003588452	.	.	.	-0.80269335	12.23755603	8.43713	0.30824	0.138	0.258	T	0.987	0.600	D	0.834	0.580	P	0.000	0.629	U	1.000	0.810	D	3.265	0.902	M	-1.08	0.771	T	-0.96	0.912	N	0.541	0.704	0.381	0.888	D	0.619	0.865	D	0.039	0.588	D	4.891	0.657	24.9	0.996	0.764	0.714	0.347	D	c	0.336	0.195	1.000	0.747	0.628	0.401	0	2.21	0.269	3.834	0.553	0.765	0.311	0.995	0.385	0.344	0.245	10.667	0.447	Ubiquitin domain|Ubiquitin-related domain	.	.	0.5	74	164	chr12	125397648	chr12:125397648	G	A	74	PASS	AN=2;DP=164	GT	0/1
chr13	20413021	20413021	T	C	exonic	ZMYM5	.	nonsynonymous SNV	ZMYM5:NM_001039650:exon5:c.A691G:p.T231A,ZMYM5:NM_001142684:exon5:c.A691G:p.T231A	0.200378135	0.7895718	0.010050066	.	0.06748	0.07051	0.485092724	79.37603208	1157.52256	6.47872	0.041	0.477	D	0.048	0.207	B	0.013	0.158	B	0.004	0.342	N	0.999	0.588	P	0	0.065	N	1.01	0.411	T	0.31	0.058	N	0.061	0.109	-1.076	0.081	T	0.000	0.001	T	.	.	.	0.786	0.169	9.378	0.947	0.247	0.822	0.412	D	c	-0.835	-0.761	0.992	0.326	0.732	0.924	0	-0.334	0.120	0.570	0.232	-0.595	0.044	0.996	0.391	0.001	0.043	4.843	0.128	.	ENSG00000196199.9|ENSG00000196199.9|ENSG00000121390.13|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000215572.2|ENSG00000196199.9	Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Muscularis|Lung|Muscle_Skeletal|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Stomach|Testis|Thyroid	0.5	129	63	chr13	20413021	chr13:20413021	T	C	129	PASS	AN=2;DP=63	GT	0/1
chr13	32882912	32882912	-	T	intronic	ZAR1L	.	.	.	.	.	.	.	.	.	0.301449681	71.80938901	237.81878	3.33	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	62	chr13	32882912	chr13:32882912	G	GT	134	PASS	AN=2;DP=62	GT	1/0
chr14	23889445	23889445	-	G	splicing	MYH7	NM_000257:exon27:c.3337-2->C	.	.	0.000145766	0.999854234	1.85E-10	DISEASE: Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10065021, ECO:0000269|PubMed:10329202, ECO:0000269|PubMed:10521296, ECO:0000269|PubMed:10563488, ECO:0000269|PubMed:10679957, ECO:0000269|PubMed:10862102, ECO:0000269|PubMed:11113006, ECO:0000269|PubMed:11133230, ECO:0000269|PubMed:11214007, ECO:0000269|PubMed:11424919, ECO:0000269|PubMed:11733062, ECO:0000269|PubMed:11861413, ECO:0000269|PubMed:11968089, ECO:0000269|PubMed:12081993, ECO:0000269|PubMed:12566107, ECO:0000269|PubMed:12590187, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12820698, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:12975413, ECO:0000269|PubMed:1417858, ECO:0000269|PubMed:15358028, ECO:0000269|PubMed:15483641, ECO:0000269|PubMed:1552912, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:15856146, ECO:0000269|PubMed:15858117, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:16267253, ECO:0000269|PubMed:1638703, ECO:0000269|PubMed:16650083, ECO:0000269|PubMed:16938236, ECO:0000269|PubMed:17372140, ECO:0000269|PubMed:18175163, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:1975517, ECO:0000269|PubMed:25182012, ECO:0000269|PubMed:7581410, ECO:0000269|PubMed:7731997, ECO:0000269|PubMed:7848441, ECO:0000269|PubMed:7874131, ECO:0000269|PubMed:8250038, ECO:0000269|PubMed:8254035, ECO:0000269|PubMed:8268932, ECO:0000269|PubMed:8282798, ECO:0000269|PubMed:8343162, ECO:0000269|PubMed:8435239, ECO:0000269|PubMed:8483915, ECO:0000269|PubMed:8655135, ECO:0000269|PubMed:8899546, ECO:0000269|PubMed:9544842, ECO:0000269|PubMed:9822100, ECO:0000269|PubMed:9829907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]: A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers. {ECO:0000269|PubMed:14520662, ECO:0000269|PubMed:15136674, ECO:0000269|PubMed:16684601, ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430]: Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. {ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11106718, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:15769782, ECO:0000269|PubMed:18506004, ECO:0000269|PubMed:21127202, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, distal, 1 (MPD1) [MIM:160500]: A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease. {ECO:0000269|PubMed:15322983, ECO:0000269|PubMed:17548557}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal recessive (MSMB) [MIM:255160]: An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy. {ECO:0000269|PubMed:25666907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43904	0.16764	-3.644803418	0.283085633	108.56923	2.26118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	198	chr14	23889445	chr14:23889445	T	TG	120	PASS	AN=2;DP=198	GT	0/1
chr14	33836421	33836421	A	T	exonic	NPAS3	.	nonsynonymous SNV	NPAS3:NM_001165893:exon3:c.A325T:p.S109C,NPAS3:NM_022123:exon3:c.A319T:p.S107C,NPAS3:NM_001164749:exon4:c.A415T:p.S139C,NPAS3:NM_173159:exon4:c.A376T:p.S126C	0.98054867	0.019451206	1.24E-07	.	0.30103	0.1462	-1.350267166	4.600141543	902.6267	5.84777	0.005	0.784	D	0.982	0.647	D	0.789	0.654	P	0.000	0.843	D	0.999	0.504	D	1.15	0.294	L	3.35	0.080	T	-2.44	0.548	N	0.703	0.771	-0.755	0.577	T	0.179	0.526	T	0.021	0.442	T	5.178	0.699	25.5	0.993	0.574	0.975	0.748	D	c	0.571	0.625	0.998	0.359	0.487	0.133	0	5.53	0.825	6.911	0.754	1.088	0.866	1.000	0.715	0.999	0.750	15.662	0.769	Myc-type, basic helix-loop-helix (bHLH) domain	.	.	0.5	99	166	chr14	33836421	chr14:33836421	A	T	99	PASS	AN=2;DP=166	GT	0/1
chr14	65009434	65009434	G	A	exonic	HSPA2	.	nonsynonymous SNV	HSPA2:NM_021979:exon1:c.G1867A:p.G623S	.	.	.	.	0.63859	.	0.130533008	63.35810333	148.46704	2.65691	0.163	0.234	T	0.016	0.161	B	0.001	0.040	B	0.304	0.040	N	0.993	0.238	N	2.045	0.562	M	5.41	0.010	T	-0.62	0.183	N	0.379	0.439	-0.852	0.519	T	0.008	0.028	T	0.015	0.360	T	1.400	0.231	12.79	0.955	0.264	0.863	0.453	D	c	-0.273	-0.158	1.000	0.747	0.767	0.994	0	3.55	0.396	4.548	0.602	0.122	0.211	1.000	0.715	0.893	0.376	8.157	0.302	Heat shock protein 70kD, C-terminal domain	.	.	0.5	91	185	chr14	65009434	chr14:65009434	G	A	91	PASS	AN=2;DP=185	GT	0/1
chr14	100594926	100594926	-	C	exonic	EVL	.	frameshift insertion	EVL:NM_001330221:exon6:c.553dupC:p.P188Tfs*107,EVL:NM_016337:exon6:c.559dupC:p.P190Tfs*107	0.99261527	0.007384449	2.82E-07	.	0.74284	0.16663	-0.359940251	28.93371078	237.51255	3.32761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	458	chr14	100594926	chr14:100594926	G	GC	94	PASS	AN=2;DP=458	GT	0/1
chr15	21938082	21938082	G	A	ncRNA_exonic	LOC646214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	72	chr15	21938082	chr15:21938082	G	A	.	PASS	AN=0;DP=72	GT	0/1
chr15	22298164	22298164	G	T	ncRNA_intronic	LINC02203;LOC101927079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	154	chr15	22298164	chr15:22298164	G	T	109	PASS	AN=2;DP=154	GT	0/1
chr15	45400207	45400207	G	A	intronic	DUOX2	.	.	.	1.90E-37	3.81E-06	0.999996187	DISEASE: Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]: A disorder due to a defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:12110737, ECO:0000269|PubMed:16134168, ECO:0000269|PubMed:16322276, ECO:0000269|PubMed:20187165}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15059	0.21524	0.227640447	68.52441614	1216.76018	6.60084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	219	chr15	45400207	chr15:45400207	G	A	65	PASS	AN=2;DP=219	GT	0/1
chr15	75981256	75981256	G	T	exonic	CSPG4	.	nonsynonymous SNV	CSPG4:NM_001897:exon3:c.C2150A:p.A717E	8.90E-05	0.999905547	5.48E-06	.	0.14288	0.14191	0.347031518	73.79098844	3644.03559	11.72399	0.417	0.099	T	0.808	0.433	P	0.274	0.383	B	0.433	0.127	N	1	0.090	N	2.6	0.763	M	1.79	0.255	T	-0.4	0.138	N	0.377	0.437	-1.081	0.072	T	0.051	0.217	T	0.010	0.255	T	-0.941	0.034	0.021	0.756	0.108	0.778	0.380	D	c	-0.083	-0.098	0.992	0.328	0.598	0.340	0	4.56	0.555	4.615	0.607	0.970	0.593	0.998	0.411	0.049	0.163	10.038	0.411	.	.	.	0.5	.	190	chr15	75981256	chr15:75981256	G	T	.	PASS	AN=0;DP=190	GT	0/1
chr15	98516888	98516888	T	C	UTR3	ARRDC4	NM_183376:c.*2471T>C	.	.	0.000815443	0.931074843	0.068109713	.	0.61153	0.10975	0.463046108	78.58575136	4696.45685	13.81768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	102	chr15	98516888	chr15:98516888	T	C	113	PASS	AN=2;DP=102	GT	0/1
chr16	1382898	1382898	-	A	upstream	BAIAP3	dist=708	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.14	171	chr16	1382898	chr16:1382898	G	GA	19.14	PASS	AN=0;DP=171	GT	0/1
chr16	16281079	16281079	C	A	intronic	ABCC6	.	.	.	1.45E-06	0.99998186	1.67E-05	DISEASE: Pseudoxanthoma elasticum (PXE) [MIM:264800]: A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings. {ECO:0000269|PubMed:10811882, ECO:0000269|PubMed:10835642, ECO:0000269|PubMed:10954200, ECO:0000269|PubMed:11427982, ECO:0000269|PubMed:11536079, ECO:0000269|PubMed:11702217, ECO:0000269|PubMed:15086542, ECO:0000269|PubMed:15098239, ECO:0000269|PubMed:15459974, ECO:0000269|PubMed:16086317, ECO:0000269|PubMed:17617515, ECO:0000269|PubMed:19339160, ECO:0000269|PubMed:20034067, ECO:0000269|PubMed:25615550}. Note=The disease is caused by mutations affecting the gene represented in this entry. Homozygous or compound heterozygous ABCC6 mutations have been found in the overwhelming majority of cases. Individuals carrying heterozygous mutations express limited manifestations of the pseudoxanthoma elasticum phenotype.; DISEASE: Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]: A severe autosomal recessive disorder characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. The disorder is often fatal within the first 6 months of life because of myocardial ischemia resulting in refractory heart failure. {ECO:0000269|PubMed:22209248}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1251	.	0.626356326	83.53974994	2678.20897	9.73052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	chr16	16281079	chr16:16281079	C	A	.	PASS	AN=0;DP=84	GT	0/1
chr16	19080213	19080213	-	A	intronic	COQ7	.	.	.	4.68E-05	0.416968957	0.582984257	.	0.15929	0.14294	-0.115612493	45.12856806	146.5872	2.6373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	244	chr16	19080213	chr16:19080213	T	TA	59	PASS	AN=2;DP=244	GT	0/1
chr16	30007664	30007664	-	A	exonic	INO80E	.	frameshift insertion	INO80E:NM_001304562:exon1:c.34dupA:p.Y15Ifs*50,INO80E:NM_001304563:exon1:c.34dupA:p.Y15Ifs*50,INO80E:NM_173618:exon1:c.34dupA:p.Y15Ifs*50	0.017414685	0.891403715	0.0911816	.	0.18786	0.11011	-0.073340031	48.11866006	41.31906	1.20769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	424	chr16	30007664	chr16:30007664	C	CA	70	PASS	AN=2;DP=424	GT	0/1
chr16	33402192	33402192	G	T	intergenic	LOC390705;ENPP7P13	dist=103490;dist=169652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	149	chr16	33402192	chr16:33402192	G	T	116	PASS	AN=2;DP=149	GT	0/1
chr16	67470052	67470052	-	C	intronic	HSD11B2	.	.	.	0.244955465	0.724823672	0.030220863	.	0.7257	0.64394	-0.47017169	23.25430526	28.64779	0.91706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	154	chr16	67470052	chr16:67470052	G	GC	45	PASS	AN=2;DP=154	GT	0/1
chr17	16097866	16097866	A	G	exonic	NCOR1	.	synonymous SNV	NCOR1:NM_001190438:exon1:c.T18C:p.Y6Y,NCOR1:NM_001190440:exon1:c.T18C:p.Y6Y,NCOR1:NM_006311:exon2:c.T18C:p.Y6Y	0.999999999	7.43E-10	7.08E-30	.	0.57767	0.62451	-2.137013188	1.49799481	297.95501	3.68236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	77	chr17	16097866	chr17:16097866	A	G	76	PASS	AN=2;DP=77	GT	0/1
chr17	18150558	18150558	G	A	exonic	FLII	.	synonymous SNV	FLII:NM_001256265:exon20:c.C2436T:p.A812A,FLII:NM_001256264:exon21:c.C2568T:p.A856A,FLII:NM_002018:exon21:c.C2601T:p.A867A	3.31E-06	0.999991566	5.12E-06	.	0.32333	0.23356	-2.936657799	0.554376032	332.27693	3.87529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	152	chr17	18150558	chr17:18150558	G	A	59	PASS	AN=2;DP=152	GT	0/1
chr17	19091405	19091405	C	G	intergenic	LOC79999;LOC79999	dist=25468;dist=27538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	1738	chr17	19091405	chr17:19091405	C	G	147	PASS	AN=2;DP=1738	GT	0/1
chr17	21205359	21205364	GGGGCT	-	intronic	MAP2K3	.	.	.	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	75	chr17	21205358	chr17:21205358	GGGGGCT	G	132	PASS	AN=2;DP=75	GT	0/1
chr17	36880975	36880975	C	T	exonic	MLLT6	.	synonymous SNV	MLLT6:NM_005937:exon19:c.C2986T:p.L996L	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	113	chr17	36880975	chr17:36880975	C	T	59	PASS	AN=2;DP=113	GT	0/1
chr17	39594694	39594694	G	A	intronic	KRT38	.	.	.	2.17E-05	0.724250939	0.275727343	.	0.08393	0.1123	-0.33061537	30.82094834	172.03352	2.86058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	92	chr17	39594694	chr17:39594694	G	A	103	PASS	AN=2;DP=92	GT	0/1
chr17	40370236	40370236	G	-	exonic	STAT5B	.	frameshift deletion	STAT5B:NM_012448:exon9:c.1102delC:p.Q368Rfs*1	0.99995316	4.68E-05	1.24E-12	DISEASE: Growth hormone insensitivity with immunodeficiency (GHII) [MIM:245590]: A disease characterized by short stature, growth hormone deficiency in the presence of normal to elevated circulating concentrations of growth hormone, resistance to hexogeneous growth hormone therapy, and recurrent infections. {ECO:0000269|PubMed:13679528, ECO:0000269|PubMed:15827093, ECO:0000269|PubMed:22419735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.50895	.	-0.890882376	10.30313753	46.4952	1.31577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	140	chr17	40370235	chr17:40370235	TG	T	73	PASS	AN=2;DP=140	GT	0/1
chr17	57762403	57762403	T	-	intronic	CLTC	.	.	.	0.999999993	6.69E-09	1.07E-22	.	0.64701	0.94571	-1.3098007	4.847841472	29.64323	0.94706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	33	chr17	57762402	chr17:57762402	CT	C	68	PASS	AN=2;DP=33	GT	0/1
chr17	58239854	58239854	C	T	intergenic	CA4;USP32	dist=2948;dist=14837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	278	chr17	58239854	chr17:58239854	C	T	61	PASS	AN=2;DP=278	GT	0/1
chr17	59465991	59465991	-	A	exonic	BCAS3	.	frameshift insertion	BCAS3:NM_001320470:exon25:c.2673dupA:p.Q895Tfs*8	0.998848202	0.001151798	1.02E-12	DISEASE: Note=A chromosomal aberration involving BCAS3 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS4.; 	0.63691	.	-0.753139731	13.67067705	343.97696	3.93313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	51	chr17	59465991	chr17:59465991	G	GA	66	PASS	AN=2;DP=51	GT	0/1
chr17	62602763	62602763	A	-	intronic	SMURF2	.	.	.	0.999989891	1.01E-05	5.97E-15	.	0.24709	0.18339	-0.690637458	15.12149092	113.88537	2.32671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	138	chr17	62602762	chr17:62602762	TA	T	83	PASS	AN=2;DP=138	GT	0/1
chr17	62852056	62852056	A	G	intronic	LRRC37A3	.	.	.	.	.	.	.	.	.	.	.	193.95095	3.02097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	178	chr17	62852056	chr17:62852056	A	G	90	PASS	AN=2;DP=178	GT	0/1
chr17	76446798	76446798	G	T	exonic	DNAH17	.	nonsynonymous SNV	DNAH17:NM_173628:exon67:c.C10865A:p.T3622N	.	.	.	.	0.10041	.	.	.	8793.71322	20.21811	.	.	.	0.009	0.139	B	0.02	0.179	B	0.002	0.385	N	0.895	0.360	D	1.065	0.271	L	-0.24	0.668	T	.	.	.	0.152	0.181	-0.930	0.441	T	0.155	0.486	T	0.006	0.164	T	1.568	0.250	13.68	0.934	0.225	0.921	0.546	D	c	-0.349	-0.193	0.171	0.177	0.615	0.372	0	2.33	0.279	1.201	0.317	0.953	0.551	0.877	0.307	1.000	0.888	9.725	0.393	.	.	.	0.5	.	102	chr17	76446798	chr17:76446798	G	T	.	PASS	AN=0;DP=102	GT	0/1
chr17	80887089	80887089	G	A	exonic	TBCD	.	nonsynonymous SNV	TBCD:NM_005993:exon31:c.G2794A:p.D932N	6.98E-05	0.999929838	3.18E-07	.	0.12203	0.11011	-1.453286053	3.892427459	630.24341	5.05995	0.095	0.312	T	0.007	0.158	B	0.037	0.218	B	0.030	0.254	N	1	0.090	N	2.395	0.694	M	-0.26	0.672	T	-1.57	0.379	N	0.071	0.077	-0.822	0.538	T	0.219	0.583	T	0.034	0.553	D	1.823	0.280	15.12	0.991	0.533	0.166	0.193	N	c	-0.469	-0.459	0.405	0.202	0.707	0.730	0	5.13	0.696	2.663	0.462	1.048	0.713	0.513	0.268	0.016	0.126	9.679	0.390	Armadillo-type fold|Tubulin-specific chaperone D, C-terminal;Tubulin-specific chaperone D, C-terminal	.	.	0.5	.	140	chr17	80887089	chr17:80887089	G	A	.	PASS	AN=0;DP=140	GT	0/1
chr18	12449301	12449301	T	-	UTR3	SPIRE1	NM_020148:c.*336delA;NM_001128627:c.*336delA;NM_001128626:c.*336delA	.	.	0.330091752	0.669881004	2.72E-05	.	0.13285	0.09444	-1.111360919	6.717386176	74.25913	1.79961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	46	27	chr18	12449300	chr18:12449300	CT	C	46	PASS	AN=2;DP=27	GT	0/1
chr18	14808654	14808654	T	C	intronic	ANKRD30B	.	.	.	1.49E-09	0.94288369	0.057116308	.	.	.	1.06196211	91.507431	2417.32649	9.13836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	139	chr18	14808654	chr18:14808654	T	C	87	PASS	AN=2;DP=139	GT	0/1
chr19	1627481	1627481	C	A	intronic	TCF3	.	.	.	0.185647144	0.813858528	0.000494328	DISEASE: Note=Chromosomal aberrations involving TCF3 are cause of forms of pre-B-cell acute lymphoblastic leukemia (B-ALL). Translocation t(1;19)(q23;p13.3) with PBX1. TCF3-PBX1 transforms cells by constitutively activating transcription of genes regulated by PBX1 or by other members of the PBX protein family (PubMed:1967983, PubMed:1671560). Translocation t(17;19)(q22;p13.3) with HLF (PubMed:1386162). Inversion inv(19)(p13;q13) with TFPT (PubMed:10086727). {ECO:0000269|PubMed:10086727, ECO:0000269|PubMed:1386162, ECO:0000269|PubMed:1671560, ECO:0000269|PubMed:1967983}.; 	0.8525	0.49369	-0.075375604	47.26350554	1035.94021	6.18027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	chr19	1627481	chr19:1627481	C	A	.	PASS	AN=0;DP=104	GT	0/1
chr19	1775123	1775123	-	CGCC	intronic	ONECUT3	.	.	.	.	.	.	.	0.08086	.	.	.	9.33211	0.34246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	58	chr19	1775123	chr19:1775123	T	TCGCC	105	PASS	AN=2;DP=58	GT	0/1
chr19	1881408	1881408	A	G	exonic	ABHD17A	.	nonsynonymous SNV	ABHD17A:NM_001130111:exon2:c.T158C:p.L53S,ABHD17A:NM_031213:exon2:c.T158C:p.L53S	0.050556875	0.860043678	0.089399447	.	.	0.11236	.	.	106.70342	2.24142	0.503	0.077	T	0.0	0.067	B	0.0	0.040	B	0.939	0.076	N	1	0.090	N	-0.345	0.033	N	1.65	0.400	T	0.06	0.063	N	0.041	0.021	-0.981	0.348	T	0.017	0.071	T	.	.	.	-1.091	0.029	0.010	0.258	0.012	0.003	0.017	N	c	-1.604	-1.530	0.999	0.396	0.722	0.854	0	0.323	0.151	0.191	0.168	0.069	0.176	0.000	0.063	0.013	0.120	6.095	0.191	.	.	.	0.5	102	176	chr19	1881408	chr19:1881408	A	G	102	PASS	AN=2;DP=176	GT	0/1
chr19	4042057	4042057	T	G	intergenic	PIAS4;ZBTB7A	dist=2673;dist=1245	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	122	chr19	4042057	chr19:4042057	T	G	45	PASS	AN=2;DP=122	GT	0/1
chr19	11564715	11564715	C	G	UTR3	ELAVL3	NM_001420:c.*626G>C;NM_032281:c.*626G>C	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	505	chr19	11564715	chr19:11564715	C	G	69	PASS	AN=2;DP=505	GT	0/1
chr19	13064214	13064214	C	-	UTR3	RAD23A	NM_001270363:c.*351delC;NM_005053:c.*351delC;NM_001270362:c.*351delC	.	.	0.039256536	0.953968382	0.006775082	.	0.75777	0.19913	0.373041938	75.29488087	343.62896	3.93038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	157	chr19	13064213	chr19:13064213	AC	A	87	PASS	AN=2;DP=157	GT	0/1
chr19	40512005	40512005	C	G	exonic	ZNF546	.	synonymous SNV	ZNF546:NM_001297763:exon4:c.C9G:p.P3P,ZNF546:NM_178544:exon4:c.C87G:p.P29P	2.54E-10	0.439925615	0.560074385	.	0.1624	.	0.606246644	82.93229535	1927.87071	8.08022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	51	chr19	40512005	chr19:40512005	C	G	97	PASS	AN=2;DP=51	GT	0/1
chr19	44981013	44981013	G	C	exonic	ZNF180	.	nonsynonymous SNV	ZNF180:NM_001278508:exon4:c.C1610G:p.S537C,ZNF180:NM_001288761:exon4:c.C656G:p.S219C,ZNF180:NM_001288762:exon4:c.C656G:p.S219C,ZNF180:NM_001278509:exon5:c.C1604G:p.S535C,ZNF180:NM_001288759:exon5:c.C1682G:p.S561C,ZNF180:NM_001291633:exon5:c.C1604G:p.S535C,ZNF180:NM_013256:exon5:c.C1685G:p.S562C,ZNF180:NM_001288760:exon7:c.C656G:p.S219C	7.36E-06	0.73046946	0.269523183	.	0.16058	.	1.157431179	92.60438783	5752.00612	15.73654	0.002	0.721	D	1.0	0.899	D	0.98	0.732	D	0.001	0.405	N	0.976	0.253	N	1.655	0.426	L	4.67	0.018	T	-4.15	0.753	D	0.429	0.485	-1.188	0.003	T	0.026	0.110	T	0.008	0.204	T	4.854	0.652	24.9	0.989	0.475	0.000	0.001	N	c	0.671	0.609	0.997	0.353	0.660	0.495	0	5.23	0.725	2.093	0.411	0.998	0.613	0.032	0.204	0.996	0.625	11.128	0.474	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	76	54	chr19	44981013	chr19:44981013	G	C	76	PASS	AN=2;DP=54	GT	0/1
chr19	45185796	45185796	G	-	intronic	CEACAM19	.	.	.	5.78E-07	0.248356946	0.751642477	.	0.14148	.	-0.003562597	53.72729417	225.41131	3.24667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	215	chr19	45185795	chr19:45185795	TG	T	65	PASS	AN=2;DP=215	GT	0/1
chr19	51729578	51729596	CCCAACAACTGGTATCTTT	-	exonic	CD33	.	frameshift deletion	CD33:NM_001082618:exon3:c.330_348del:p.P111Qfs*37,CD33:NM_001177608:exon4:c.711_729del:p.P238Qfs*37,CD33:NM_001772:exon4:c.711_729del:p.P238Qfs*37	2.31E-05	0.497999066	0.501977871	.	0.03502	0.08119	2.289361599	98.30738382	1143.30228	6.44529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	25	chr19	51729577	chr19:51729577	ACCCAACAACTGGTATCTTT	A	97	PASS	AN=2;DP=25	GT	0/1
chr19	54245839	54245839	-	GT	ncRNA_exonic	MIR520H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	45	chr19	54245839	chr19:54245839	A	AGT	98	PASS	AN=2;DP=45	GT	0/1
chr19	55278630	55278630	G	C	intergenic	KIR2DL3;LOC101928804	dist=14126;dist=2244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	128	chr19	55278630	chr19:55278630	G	C	101	PASS	AN=2;DP=128	GT	0/1
chr19	55278668	55278668	C	G	intergenic	KIR2DL3;LOC101928804	dist=14164;dist=2206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.169	0.079	1.273	0.398	0.027	0.015	0.050	N	n	-0.207	-0.202	0.000	0.012	0.054	0.004	0	-0.381	0.118	0.263	0.181	0.397	0.275	0.328	0.253	0.006	0.095	4.532	0.113	.	.	.	0.5	88	102	chr19	55278668	chr19:55278668	C	G	88	PASS	AN=2;DP=102	GT	0/1
chr19	56372787	56372787	G	T	exonic	NLRP4	.	nonsynonymous SNV	NLRP4:NM_134444:exon4:c.G1892T:p.C631F	5.16E-05	0.992920234	0.007028169	.	0.07498	0.09698	0.216698013	67.92285916	73.01576	1.78351	0.001	0.784	D	1.0	0.899	D	0.988	0.764	D	.	.	.	0.738	0.338	D	1.44	0.361	L	-2.46	0.889	D	-9.24	0.983	D	0.485	0.533	0.463	0.900	D	0.740	0.911	D	0.063	0.689	D	2.952	0.415	22.1	0.990	0.488	0.530	0.290	D	c	0.012	-0.157	0.000	0.038	0.554	0.246	0	2.34	0.279	0.890	0.277	0.108	0.203	0.209	0.242	0.174	0.211	4.969	0.134	Leucine-rich repeat domain, L domain-like	.	.	0.5	.	46	chr19	56372787	chr19:56372787	G	T	.	PASS	AN=0;DP=46	GT	0/1
chr20	23667683	23667683	C	G	intronic	CST4	.	.	.	7.30E-06	0.161904959	0.838087741	.	0.09154	0.1077	0.262810045	70.43524416	20.08609	0.68634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	281	chr20	23667683	chr20:23667683	C	G	117	PASS	AN=2;DP=281	GT	0/1
chr21	36265324	36265324	T	-	intronic	RUNX1	.	.	.	0.449323607	0.549373498	0.001302896	DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of M2 type acute myeloid leukemia (AML-M2). Translocation t(8;21)(q22;q22) with RUNX1T1.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of therapy-related myelodysplastic syndrome (T-MDS). Translocation t(3;21)(q26;q22) with EAP or MECOM.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H.; DISEASE: Note=A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein.; DISEASE: Familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]: Autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia. {ECO:0000269|PubMed:10508512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.; 	0.71814	0.72461	-0.227663163	37.11370606	85.67689	1.97553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	167	chr21	36265323	chr21:36265323	CT	C	117	PASS	AN=2;DP=167	GT	0/1
chr21	38092248	38092248	A	-	intronic	SIM2	.	.	.	0.178825369	0.820642349	0.000532282	.	0.36242	0.24747	-0.198338176	39.17197452	2208.64464	8.65301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	107	chr21	38092247	chr21:38092247	GA	G	87	PASS	AN=2;DP=107	GT	0/1
chr21	46945700	46945700	C	-	intronic	SLC19A1	.	.	.	0.0123881	0.952273227	0.035338672	.	0.0749	.	-0.286522835	33.47487615	1149.843	6.46099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	310	chr21	46945699	chr21:46945699	TC	T	95	PASS	AN=2;DP=310	GT	0/1
chr22	18166016	18166072	AAGAAATTTTATTAAAAGTTAAAACTGAAATTGAAGAAGAGCTAAAATCTCTGGACA	-	exonic	BCL2L13	.	nonframeshift deletion	BCL2L13:NM_001270726:exon2:c.230_286del:p.L80_I98del,BCL2L13:NM_001270727:exon2:c.230_286del:p.L80_I98del,BCL2L13:NM_001270732:exon3:c.158_214del:p.L56_I74del,BCL2L13:NM_001270734:exon3:c.158_214del:p.L56_I74del,BCL2L13:NM_001270735:exon3:c.158_214del:p.L56_I74del,BCL2L13:NM_015367:exon3:c.158_214del:p.L56_I74del	0.070274402	0.916561026	0.013164572	.	0.0591	.	0.50895761	80.20169851	191.37406	3.0001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	92	chr22	18166015	chr22:18166015	CAAGAAATTTTATTAAAAGTTAAAACTGAAATTGAAGAAGAGCTAAAATCTCTGGACA	C	54	PASS	AN=2;DP=92	GT	0/1
chr22	18861064	18861064	T	C	ncRNA_exonic	LINC01663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	2254	chr22	18861064	chr22:18861064	T	C	133	PASS	AN=2;DP=2254	GT	0/1
chr22	23656859	23656859	T	C	exonic	BCR	.	synonymous SNV	BCR:NM_021574:exon21:c.T3552C:p.P1184P,BCR:NM_004327:exon22:c.T3684C:p.P1228P	0.999967225	3.28E-05	1.05E-13	DISEASE: Leukemia, chronic myeloid (CML) [MIM:608232]: A clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome (Ph), involving myeloid, erythroid, megakaryocytic, B-lymphoid, and sometimes T-lymphoid cells, but not marrow fibroblasts. {ECO:0000269|PubMed:2407300, ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:3540951}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Note=A chromosomal aberration involving BCR has been found in patients with chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). {ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:7665185}.; 	0.27882	0.76444	-1.253015116	5.360934183	625.45504	5.04431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	331	chr22	23656859	chr22:23656859	T	C	136	PASS	AN=2;DP=331	GT	0/1
chr22	24658397	24658397	C	T	ncRNA_exonic	POM121L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	498	chr22	24658397	chr22:24658397	C	T	107	PASS	AN=2;DP=498	GT	0/1
chr22	29130347	29130347	-	T	intronic	CHEK2	.	.	.	1.18E-15	0.005518936	0.994481064	DISEASE: Li-Fraumeni syndrome 2 (LFS2) [MIM:609265]: A highly penetrant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:11719428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:12533788}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteogenic sarcoma (OSRC) [MIM:259500]: A sarcoma originating in bone-forming cells, affecting the ends of long bones. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:12094328, ECO:0000269|PubMed:21618645, ECO:0000269|PubMed:25619829}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000269|PubMed:12094328}.; 	0.98514	0.65565	-0.134019284	43.90776126	138.54243	2.56375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	101	15	chr22	29130347	chr22:29130347	G	GT	101	PASS	AN=2;DP=15	GT	1/1
chr22	38995742	38995742	G	A	intronic	FAM227A	.	.	.	.	.	.	.	.	.	.	.	358.7527	4.01183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr22	38995742	chr22:38995742	G	A	.	PASS	AN=0;DP=66	GT	0/1
chr22	50927718	50927718	C	T	exonic	MIOX	.	nonsynonymous SNV	MIOX:NM_017584:exon7:c.C580T:p.H194Y	4.60E-12	0.014039927	0.985960073	.	0.17947	0.12797	-0.200157416	39.11299835	99.70995	2.16398	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	-5.8	0.881	D	0.813	0.874	0.368	0.886	D	0.578	0.848	D	0.084	0.743	D	5.840	0.800	27.3	0.997	0.820	0.976	0.754	D	c	0.774	0.669	1.000	0.747	0.581	0.326	0	5.14	0.699	3.575	0.534	0.865	0.377	1.000	0.715	0.950	0.426	16.098	0.809	.	.	.	0.5	58	55	chr22	50927718	chr22:50927718	C	T	58	PASS	AN=2;DP=55	GT	0/1
chrX	22012649	22012649	-	T	UTR3	SMS	NM_004595:c.*180_*181insT;NM_001258423:c.*180_*181insT	.	.	0.921460277	0.078440686	9.90E-05	DISEASE: X-linked syndromic mental retardation Snyder-Robinson type (MRXSSR) [MIM:309583]: Characterized by moderate intellectual deficit, hypotonia, an unsteady gait, osteoporosis, kyphoscoliosis and facial asymmetry. Transmission is X-linked recessive. {ECO:0000269|PubMed:14508504, ECO:0000269|PubMed:22612257}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.58047	0.10879	-0.295622497	32.61972163	8.98969	0.33022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	84	chrX	22012649	chrX:22012649	G	GT	72	PASS	AN=2;DP=84	GT	0/1
chrX	30715762	30715762	-	A	intronic	GK	.	.	.	0.90325865	0.096734397	6.95E-06	.	.	0.4441	-0.273576253	33.97027601	4.23799	0.15391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	51	chrX	30715762	chrX:30715762	G	GA	58	PASS	AN=2;DP=51	GT	0/1
chrX	48661515	48661515	-	T	intronic	HDAC6	.	.	.	0.999920798	7.92E-05	2.20E-11	DISEASE: Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia (CDP-PBHM) [MIM:300863]: A disease characterized by chondrodysplasia, severe platyspondyly, hydrocephaly, and facial features with microphthalmia. Bone abnormalities include a distinctive metaphyseal cupping of the metacarpals, metatarsals, and phalanges. Affected females show a milder phenotype with small stature, sometimes associated with body asymmetry and mild mental retardation. {ECO:0000269|PubMed:20181727}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1462	0.18896	0.069852974	59.10592121	228.99662	3.26923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	86	chrX	48661515	chrX:48661515	C	CT	68	PASS	AN=2;DP=86	GT	0/1
chrX	73072090	73072090	-	A	ncRNA_exonic	XIST	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	300	chrX	73072090	chrX:73072090	G	GA	71	PASS	AN=2;DP=300	GT	0/1
chrX	84534441	84534441	-	A	intronic	POF1B	.	.	.	0.000181225	0.972919214	0.026899561	DISEASE: Premature ovarian failure 2B (POF2B) [MIM:300604]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:16773570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14231	0.41445	0.92967242	89.79122435	227.93995	3.26029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	79	chrX	84534441	chrX:84534441	G	GA	51	PASS	AN=2;DP=79	GT	0/1
chrX	129536209	129536209	C	-	intronic	RBMX2	.	.	.	0.772803906	0.225526116	0.001669978	.	0.0606	0.39625	0.170987912	65.5579146	19.54878	0.67128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	488	chrX	129536208	chrX:129536208	AC	A	119	PASS	AN=2;DP=488	GT	0/1
